Page last updated: 2024-09-02

schizandrin b and wortmannin

schizandrin b has been researched along with wortmannin in 2 studies

Compound Research Comparison

Studies (schizandrin b)	Trials (schizandrin b)	Recent Studies (post-2010) (schizandrin b)	Studies (wortmannin)	Trials (wortmannin)	Recent Studies (post-2010) (wortmannin)
321	1	218	4,066	2	726
9	0	7	4,066	2	726

Protein Interaction Comparison

Protein	Taxonomy	wortmannin (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens (human)	0.0465
Myosin light chain kinase, smooth muscle	Gallus gallus (chicken)	0.26
Metabotropic glutamate receptor 1	Rattus norvegicus (Norway rat)	0.0085
Phosphatidylinositol 3-kinase regulatory subunit alpha	Homo sapiens (human)	0.2368
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	Homo sapiens (human)	0.1309
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	Homo sapiens (human)	0.0493
Serine/threonine-protein kinase mTOR	Homo sapiens (human)	0.04
Phosphatidylinositol 4-kinase alpha	Homo sapiens (human)	0.28
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	Homo sapiens (human)	0.0492
Serine/threonine-protein kinase PLK1	Homo sapiens (human)	0.4433
Myosin light chain kinase, smooth muscle	Homo sapiens (human)	2.3567
Phosphoinositide 3-kinase regulatory subunit 5	Homo sapiens (human)	0.019
Serine/threonine-protein kinase PLK3	Homo sapiens (human)	0.1057
Phosphatidylinositol 4-kinase beta	Homo sapiens (human)	0.44

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Finlay, MR; Griffin, RJ	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1

Reviews

1 review(s) available for schizandrin b and wortmannin

Article	Year
Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family. Bioorganic & medicinal chemistry letters, 2012, Sep-01, Volume: 22, Issue:17 Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA; DNA Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Humans; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Tumor Suppressor Proteins	2012

Article

Year

Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.

Bioorganic & medicinal chemistry letters, 2012, Sep-01, Volume: 22, Issue:17

Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA; DNA Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Humans; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Tumor Suppressor Proteins

2012

Other Studies

1 other study(ies) available for schizandrin b and wortmannin

Article	Year
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012

Article

Year

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012